Zacks: Consort Medical plc (CSRMY) Given Average Recommendation of “Strong Buy” by Brokerages
Consort Medical plc (NASDAQ:CSRMY) has been assigned an average broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the company, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy rating.
Zacks has also given Consort Medical plc an industry rank of 88 out of 265 based on the ratings given to related companies.
Separately, Zacks Investment Research raised shares of Consort Medical plc from a “hold” rating to a “buy” rating and set a $16.00 target price on the stock in a research report on Tuesday, June 6th.
Shares of Consort Medical plc (NASDAQ:CSRMY) traded down 6.33% during midday trading on Monday, reaching $14.05. 209 shares of the company traded hands. Consort Medical plc has a 1-year low of $12.90 and a 1-year high of $15.00. The company has a 50 day moving average price of $14.81 and a 200 day moving average price of $13.86. The company has a market capitalization of $687.23 million and a PE ratio of 23.77.
About Consort Medical plc
Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Consort Medical plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical plc and related companies with MarketBeat.com's FREE daily email newsletter.